Gene · 4923
Papers2,119
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,119
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| State-dependent neurotensin modulation in the brain: From network dynamics to pharmacological opportunity. | Curr Opin Pharmacol | 2026 | 42176564 | PubTator, text mining | PubMed |
| Advances in research on radiopharmaceuticals targeting NTSR1. | Eur J Med Chem | 2026 | 42155169 | PubTator, text mining | PubMed |
| Amonafide Targeting NTSR1-PI3K/AKT/mTOR Signaling Attenuates Vascular Remodeling in Pulmonary Arterial Hypertension. | J Am Heart Assoc | 2026 | 42132175 | PubTator, text mining | PubMed |
| Circulating plasma protein biomarkers associated with risk of negative clinical outcomes in virally suppressed people with HIV receiving medications for opioid use disorder. | Front Mol Biosci | 2026 | 42131086 | PubTator, text mining | PubMed |
| Neurotensin Receptor 1 Regulates HER4 Tyrosine Phosphorylation in Lung Cancer Cells. | Biology (Basel) | 2026 | 42117825 | PubTator, text mining | PubMed |
| Advances in neurotensin receptor 1-targeted molecular probes for tumor molecular imaging and therapy. | Front Oncol | 2026 | 42109681 | PubTator, text mining | PubMed |
| A neurotensin receptor type 1-derived pepducin acts as a biased allosteric modulator to regulate target receptor function. | Acta Pharm Sin B | 2026 | 42039273 | PubTator, text mining | PubMed |
| Radionuclide-based pharmaceuticals for breast cancer imaging: state of the art. | EJNMMI Radiopharm Chem | 2026 | 42035386 | PubTator, text mining | PubMed |
| Draft genome sequences of four Rhizobium spp. isolates, including one potential new species, from tropical legume plants in Costa Rica. | Access Microbiol | 2026 | 41938076 | PubTator, text mining | PubMed |
| PACS1 syndrome mutation disrupts dynein-mediated cargo transport via HDAC6 and BICD2. | Commun Biol | 2026 | 41888583 | PubTator, text mining | PubMed |
| Targeting oncogenic NTSR1 with liensinine reprograms Gq-mediated signaling to suppress lung adenocarcinoma. | Chin Med | 2026 | 41877179 | PubTator, text mining | PubMed |
| Explainable AI for gastrointestinal lesion surveillance and precision targeted drug delivery. | Sci Rep | 2026 | 41872672 | PubTator, text mining | PubMed |
| The Interaction of Neutrophil Extracellular Traps and Complement in Intracerebral Hemorrhage. | Cell Mol Neurobiol | 2026 | 41857255 | PubTator, text mining | PubMed |
| The dynamic basis of G-protein recognition and activation by a GPCR. | Nature | 2026 | 41813902 | PubTator, text mining | PubMed |
| Snapshots of the dynamic basis of NTSR1 G protein subtype promiscuity. | Nature | 2026 | 41813894 | PubTator, text mining | PubMed |
| ABEL-FRET bridges the timescale gap in single-molecule measurements of the structural dynamics in the A2A adenosine receptor. | Commun Chem | 2026 | 41803331 | PubTator, text mining | PubMed |
| Advances in intratumoral immunotherapy from a neuro-immune-endocrine perspective for breast cancer treatment. | Front Oncol | 2026 | 41800053 | PubTator, text mining | PubMed |
| Latest surface plasmon resonance advances for G protein-coupled receptors. | J Pharm Anal | 2026 | 41767747 | PubTator, text mining | PubMed |
| Molecular mechanisms and classification of castration-resistant prostate cancer: Insights into androgen receptor, cancer stem cells, and neuroendocrine features. | Curr Urol | 2026 | 41743916 | PubTator, text mining | PubMed |
| Two axolotl-adapted cell-ablation platforms reveal macrophage-dependent processes essential for spinal-cord and skeletal regeneration. | bioRxiv | 2026 | 41727137 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4923/papers?page=2